Concepedia

Prashanth Hari Dass

PH

Statistics

Publications

2

Citations

109

H-Index

2

Active since

2022

Affiliations

Incyte (United States)(Current)

Prashanth Hari Dass is an author at Incyte (United States) specializing in cancer immunology, immunotherapy, and oncology.

ORCID

Publications per year

2022–2024

2

Publications

2

First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors

Elizabeth J. Davis, Juan Martín-Liberal, Rebecca Kristeleit et al. · Journal for ImmunoTherapy of Cancer · 2022 · 93 citations · Full text

, , +16

Ketogenic metabolic therapy in conjunction with standard treatment for glioblastoma: A case report

Matthew Phillips, Ziad Thotathil, Prashanth Hari Dass et al. · Oncology Letters · 2024 · 16 citations · Full text

, , +17

1–2 of 2